Inrobics
Inrobics introduces a transformative AI platform that harnesses the potential of social robots to enrich the lives of individuals with functional or neurological disorders. At the core of this innovation lies a blend of technology and compassion, as Inrobics employs robots like NAO, Pepper, and Romeo to offer personalized therapeutic interactions.
Operating as an embedded AI solution, Inrobics leverages the familiarity of social robots to engage patients in tailored therapies that cater to their unique needs and preferences. This not only enhances treatment effectiveness but also provides a pathway to progress monitoring.
Deployed in rehabilitation centers and homes alike, Inrobics' cloud-based platform offers a seamless experience, ensuring ease of use and accessibility. By fostering engagement and effectiveness, Inrobics stands as a beacon of hope for those seeking enhanced quality of life while alleviating the burdens on caregivers and therapists through its innovative feedback system.
Inrobics' holistic approach underscores how technology can compassionately address health challenges, contributing to improved well-being and independence. Through the harmony of AI, social robotics, and personalized care, Inrobics paves the way for a future where innovation becomes a catalyst for a brighter tomorrow.
Detailed information:
- Founded: 2019
- Founder: Dr. David Cuesta
- Headquarters: Marid, Spain
- Instagram: https://www.instagram.com/inrobics
- Website: https://inrobics.com/
